Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02650804
Title BPM31510 Administered Intravenously With or Without Gemcitabine in Advanced Pancreatic Cancer Patients
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Berg, LLC
Indications

pancreatic adenocarcinoma

Therapies

BPM 31510

BPM 31510 + Gemcitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.